Increased PARylation impacts the DNA methylation process in type 2 diabetes mellitus

BACKGROUND: Epigenetic modifications, such as DNA methylation, can influence the genetic susceptibility to type 2 diabetes mellitus (T2DM) and the progression of the disease. Our previous studies demonstrated that the regulation of the DNA methylation pattern involves the poly(ADP-ribosyl)ation (PARylation) process, a post-translational modification of proteins catalysed by the poly(ADP-ribose) polymerase (PARP) enzymes. Experimental data showed that the hyperactivation of PARylation is associated with impaired glucose metabolism and the development of T2DM. Aims of this case-control study were to investigate the association between PARylation and global and site-specific DNA methylation in T2DM and to evaluate metabolic correlates.

RESULTS: Data were collected from 61 subjects affected by T2DM and 48 healthy individuals, recruited as controls. Global levels of poly(ADP-ribose) (PAR, a surrogate of PARP activity), cytosine methylation (5-methylcytosine, 5mC) and de-methylation intermediates 5-hydroxymethylcytosine (5hmC) and 5-formylcytosine (5fC) were determined in peripheral blood cells by ELISA-based methodologies. Site-specific DNA methylation profiling of SOCS3, SREBF1 and TXNIP candidate genes was performed by mass spectrometry-based bisulfite sequencing, methyl-sensitive endonucleases digestion and by DNA immuno-precipitation. T2DM subjects presented higher PAR levels than controls. In T2DM individuals, increased PAR levels were significantly associated with higher HbA1c levels and the accumulation of the de-methylation intermediates 5hmC and 5fC in the genome. In addition, T2DM patients with higher PAR levels showed reduced methylation with increased 5hmC and 5fC levels in specific SOCS3 sites, up-regulated SOCS3 expression compared to both T2DM subjects with low PAR levels and controls.

CONCLUSIONS: This study demonstrates the activation of PARylation processes in patients with T2DM, particularly in those with poor glycaemic control. PARylation is linked to dysregulation of DNA methylation pattern via activation of the DNA de-methylation cascade and may be at the basis of the differential gene expression observed in presence of diabetes.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Clinical epigenetics - 13(2021), 1 vom: 17. Mai, Seite 114

Sprache:

Englisch

Beteiligte Personen:

Zampieri, Michele [VerfasserIn]
Bacalini, Maria Giulia [VerfasserIn]
Barchetta, Ilaria [VerfasserIn]
Scalea, Stefania [VerfasserIn]
Cimini, Flavia Agata [VerfasserIn]
Bertoccini, Laura [VerfasserIn]
Tagliatesta, Stefano [VerfasserIn]
De Matteis, Giovanna [VerfasserIn]
Zardo, Giuseppe [VerfasserIn]
Cavallo, Maria Gisella [VerfasserIn]
Reale, Anna [VerfasserIn]

Links:

Volltext

Themen:

5-Hydroxymethylcytosine
DNA methylation
Epigenetics
Journal Article
PARylation
Research Support, Non-U.S. Gov't
Type 2 diabetes mellitus

Anmerkungen:

Date Completed 24.01.2022

Date Revised 24.01.2022

published: Electronic

Citation Status MEDLINE

doi:

10.1186/s13148-021-01099-1

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM32552419X